New combo therapy aims to ease overactive bladder in women
NCT ID NCT07429734
First seen Feb 26, 2026 · Last updated Jun 16, 2026 · Updated 15 times
Summary
This study tests whether adding gabapentin to the standard drug solifenacin works better than solifenacin alone for women with overactive bladder. About 60 women will receive either the combination or the single drug, and researchers will track symptom changes and side effects over three months. The goal is to find a more effective way to reduce urgency, frequency, and leakage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.